Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Ichimura

Showing results (261-270 of 298) with videos related to

Pageof 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade GliomaJo Sasame, Naoki Ikegaya, Masahito Kawazu, et al.
Nature Communications|August 2, 2022
A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumorsKyuto Sonehara, Yui Kimura, Yoshiko Nakano, et al.
Neuro-Oncology|October 26, 2021
12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumorsKaishi Satomi, Hirokazu Takami, Shintaro Fukushima, et al.
Scientific Reports|January 1, 2020
Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural networkRyohei Fukuma, Takufumi Yanagisawa, Manabu Kinoshita, et al.
Cancers|April 3, 2021
Fine-Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among FacilitiesSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Acta Neuropathologica|May 2, 2015
Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gainChristoph Geisenberger, Andreas Mock, Rolf Warta, et al.
Neuro-Oncology|August 18, 2019
Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT ConsortiumHirokazu Takami, Kohei Fukuoka, Shintaro Fukushima, et al.
JCO Precision Oncology|July 6, 2023
Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR ProjectKayoko Tao, Fumito Yamazaki, Takashi Kubo, et al.
Journal of Neuro-Oncology|May 22, 2015
Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumorsHirokazu Takami, Shintaro Fukushima, Kohei Fukuoka, et al.
Acta Neuropathologica|January 7, 2017
Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphomaTaishi Nakamura, Satoshi Yamashita, Kazutaka Fukumura, et al.
Pageof 30

Showing results (261-270 of 298) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2022
HSP90 Inhibition Overcomes Resistance to Molecular Targeted Therapy in BRAFV600E-mutant High-grade GliomaJo Sasame, Naoki Ikegaya, Masahito Kawazu, et al.
Nature Communications|August 2, 2022
A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumorsKyuto Sonehara, Yui Kimura, Yoshiko Nakano, et al.
Neuro-Oncology|October 26, 2021
12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumorsKaishi Satomi, Hirokazu Takami, Shintaro Fukushima, et al.
Scientific Reports|January 1, 2020
Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural networkRyohei Fukuma, Takufumi Yanagisawa, Manabu Kinoshita, et al.
Cancers|April 3, 2021
Fine-Tuning Approach for Segmentation of Gliomas in Brain Magnetic Resonance Images with a Machine Learning Method to Normalize Image Differences among FacilitiesSatoshi Takahashi, Masamichi Takahashi, Manabu Kinoshita, et al.
Acta Neuropathologica|May 2, 2015
Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gainChristoph Geisenberger, Andreas Mock, Rolf Warta, et al.
Neuro-Oncology|August 18, 2019
Integrated clinical, histopathological, and molecular data analysis of 190 central nervous system germ cell tumors from the iGCT ConsortiumHirokazu Takami, Kohei Fukuoka, Shintaro Fukushima, et al.
JCO Precision Oncology|July 6, 2023
Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR ProjectKayoko Tao, Fumito Yamazaki, Takashi Kubo, et al.
Journal of Neuro-Oncology|May 22, 2015
Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumorsHirokazu Takami, Shintaro Fukushima, Kohei Fukuoka, et al.
Acta Neuropathologica|January 7, 2017
Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphomaTaishi Nakamura, Satoshi Yamashita, Kazutaka Fukumura, et al.
Pageof 30